Treatment of cognitive dysfunction in major depressive disorder - A review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine

European Journal of Pharmacology

Volumn 753, Issue , 2015, Pages 19-31

  Pehrson, Alan L ^a   Leiser, Steven C ^a   Gulinello, Maria ^b   Dale, Elena ^a   Li, Yan ^a   Waller, Jessica A ^a   Sanchez, Connie ^a  

^a LUNDBECK RESEARCH USA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cognitive function; Electrophysiology; Lu AA21004; Major depressive disorder; Receptor occupancy; Vortioxetine

Indexed keywords

CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE; VORTIOXETINE; ZIMELDINE; ANTIDEPRESSANT AGENT; PIPERAZINE DERIVATIVE; SULFIDE;

ARTICLE; ATTENTION DEFICIT DISORDER; CELL DENSITY; CELL PROLIFERATION; CELL SURVIVAL; COGNITIVE DEFECT; DELTA RHYTHM; DRUG EFFICACY; DRUG MECHANISM; EXECUTIVE FUNCTION; GABAERGIC TRANSMISSION; GAMMA RHYTHM; HUMAN; LONG TERM POTENTIATION; MAJOR DEPRESSION; MEMORY DISORDER; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RECOGNITION; SPATIAL MEMORY; THETA RHYTHM; WORKING MEMORY; ANIMAL; COGNITION; DRUG EFFECTS;

ANIMALS; ANTIDEPRESSIVE AGENTS; COGNITION; PIPERAZINES; SEROTONIN AND NORADRENALINE REUPTAKE INHIBITORS; SEROTONIN UPTAKE INHIBITORS; SULFIDES;

EID: 84925584026     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.07.044     Document Type: Article

References (191)

1. T. Alkam, M. Hiramatsu, T. Mamiya, Y. Aoyama, A. Nitta, K. Yamada, H.C. Kim, and T. Nabeshima Evaluation of object-based attention in mice Behav. Brain Res. 220 2011 185 193
2. R. Andrade Serotonergic regulation of neuronal excitability in the prefrontal cortex Neuropharmacology 61 2011 382 386
3. J. Areberg, M. Luntang-Jensen, B. Sogaard, and D.O. Nilausen Occupancy of the serotonin transporter after administration of Lu AA21004 and its relation to plasma concentration in healthy subjects Basic Clin. Pharmacol. Toxicol. 110 2012 401 404
4. C.R. Ashby Jr., Y. Minabe, E. Edwards, and R.Y. Wang 5-HT3-like receptors in the rat medial prefrontal cortex: an electrophysiological study Brain Res. 550 1991 181 191
5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013 American Psychiatric Association Washington, DC
6. P.J. Baarendse, and L.J. Vanderschuren Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats Psychopharmacology 219 2012 313 326
7. B. Bang-Andersen, T. Ruhland, M. Jorgensen, G. Smith, K. Frederiksen, K.G. Jensen, H. Zhong, S.M. Nielsen, S. Hogg, A. Mork, and T.B. Stensbol Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder J. Med. Chem. 54 2011 3206 3221
8. A. Barco, and H. Marie Genetic approaches to investigate the role of CREB in neuronal plasticity and memory Mol. Neurobiol. 44 2011 330 349
9. A. Bari, D.E. Theobald, D. Caprioli, A.C. Mar, A. Aidoo-Micah, J.W. Dalley, and T.W. Robbins Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats Neuropsychopharmacology 35 2010 1290 1301
10. E. Basar, C. Basar-Eroglu, S. Karakas, and M. Schurmann Are cognitive processes manifested in event-related gamma, alpha, theta and delta oscillations in the EEG? Neurosci. Lett. 259 1999 165 168
11. E. Basar, C. Basar-Eroglu, S. Karakas, and M. Schurmann Brain oscillations in perception and memory Int. J. Psychophysiol. 35 2000 95 124
12. E. Basar, C. Basar-Eroglu, S. Karakas, and M. Schurmann Gamma, alpha, delta, and theta oscillations govern cognitive processes Int. J. Psychophysiol. 39 2001 241 248
13. E. Basar, and B. Guntekin A review of brain oscillations in cognitive disorders and the role of neurotransmitters Brain Res. 1235 2008 172 193
14. B.T. Baune, T. Suslow, A. Engelien, V. Arolt, and K. Berger The association between depressive mood and cognitive performance in an elderly general population - the MEMO Study Dement. Geriatr. Cogn. Disord. 22 2006 142 149
15. J. Beiko, L. Candusso, and D.P. Cain The effect of nonspatial water maze pretraining in rats subjected to serotonin depletion and muscarinic receptor antagonism: a detailed behavioural assessment of spatial performance Behav. Brain Res. 88 1997 201 211
16. C. Bell, S. Wilson, A. Rich, J. Bailey, and D. Nutt Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers Psychopharmacology 166 2003 102 110
17. R. Benavides-Piccione, I. Fernaud-Espinosa, V. Robles, R. Yuste, and J. DeFelipe Age-based comparison of human dendritic spine structure using complete three-dimensional reconstructions Cereb. Cortex 23 2013 1798 1810
18. J.M. Bessa, D. Ferreira, I. Melo, F. Marques, J.J. Cerqueira, J.A. Palha, O.F. Almeida, and N. Sousa The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling Mol. Psychiatry 14 764-773 2009 739
19. C. Betry, A.L. Pehrson, A. Etievant, B. Ebert, C. Sanchez, and N. Haddjeri The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism Int. J. Neuropsychopharmacol. 16 2013 1115 1127
20. M. Bianchi, K.C. Fone, A.J. Shah, A.R. Atkins, L.A. Dawson, C.A. Heidbreder, J.J. Hagan, and C.A. Marsden Chronic fluoxetine differentially modulates the hippocampal microtubular and serotonergic system in grouped and isolation reared rats Eur. Neuropsychopharmacol. 19 2009 778 790
21. E. Biringer, A. Mykletun, A.A. Dahl, A.D. Smith, K. Engedal, H.A. Nygaard, and A. Lund The association between depression, anxiety, and cognitive function in the elderly general population - the Hordaland health study Int. J. Geriatr. Psychiatry 20 2005 989 997
22. B. Bjorvatn, A.A. Bjorkum, D. Neckelmann, and R. Ursin Sleep/waking and EEG power spectrum effects of a nonselective serotonin (5-HT) antagonist and a selective 5-HT reuptake inhibitor given alone and in combination Sleep 18 1995 451 462
23. A. Blokland, C. Lieben, and N.E. Deutz Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat J. Psychopharmacol. 16 2002 39 49
24. C.O. Bondi, G. Rodriguez, G.G. Gould, A. Frazer, and D.A. Morilak Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment Neuropsychopharmacology 33 2008 320 331
25. K.A. Bordner, R.R. Kitchen, B. Carlyle, E.D. George, M.C. Mahajan, S.M. Mane, J.R. Taylor, and A.A. Simen Parallel declines in cognition, motivation, and locomotion in aging mice: association with immune gene upregulation in the medial prefrontal cortex Exp. Gerontol. 46 2011 643 659
26. A. Bridoux, C. Laloux, P. Derambure, R. Bordet, and C. Monaca Charley The acute inhibition of rapid eye movement sleep by citalopram may impair spatial learning and passive avoidance in mice J. Neural Transm. 120 2013 383 389
27. A. Briones, S. Gagno, E. Martisova, M. Dobarro, B. Aisa, M. Solas, R. Tordera, and M. Ramirez Stress-induced anhedonia is associated with an increase in Alzheimers disease-related markers Br. J. Pharmacol. 165 2012 897 907
28. H.D. Brown, D.A. Amodeo, J.A. Sweeney, and M.E. Ragozzino The selective serotonin reuptake inhibitor, escitalopram, enhances inhibition of prepotent responding and spatial reversal learning J. Psychopharmacol. 26 2012 1443 1455
29. N.S. Burghardt, D.E. Bush, B.S. McEwen, and J.E. LeDoux Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist Biol. Psychiatry 62 2007 1111 1118
30. N.S. Burghardt, E.H. Park, R. Hen, and A.A. Fenton Adult-born hippocampal neurons promote cognitive flexibility in mice Hippocampus 22 2012 1795 1808
31. V.P. Carlini, R.C. Gaydou, H.B. Schioth, and S.R. de Barioglio Selective serotonin reuptake inhibitor (fluoxetine) decreases the effects of ghrelin on memory retention and food intake Regul. Pept. 140 2007 65 73
32. V.P. Carlini, M.B. Poretti, M. Rask-Andersen, R.A. Chavan, M.F. Ponzio, R.S. Sawant, S.R. de Barioglio, H.B. Schioth, and M.F. de Cuneo Differential effects of fluoxetine and venlafaxine on memory recognition: possible mechanisms of action Prog. Neuropsychopharmacol. Biol. Psychiatry 38 2012 159 167
33. S. Chalon, A. Pereira, E. Lainey, F. Vandenhende, J.G. Watkin, L. Staner, and L.A. Granier Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects Psychopharmacology 177 2005 357 365
34. C.D. Conrad A critical review of chronic stress effects on spatial learning and memory Prog. Neuropsychopharmacol. Biol. Psychiatry 34 2010 742 755
35. H.J. Conradi, J. Ormel, and P. de Jonge Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study Psychol. Med. 41 2011 1165 1174
36. A.L. Coppell, Q. Pei, and T.S. Zetterstrom Bi-phasic change in BDNF gene expression following antidepressant drug treatment Neuropharmacology 44 2003 903 910
37. R. Corradetti, L. Ballerini, A.M. Pugliese, and G. Pepeu Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices Neuroscience 46 1992 511 518
38. P.E. Croarkin, A.J. Levinson, and Z.J. Daskalakis Evidence for GABAergic inhibitory deficits in major depressive disorder Neurosci. Biobehav. Rev. 35 2011 818 825
39. G. Cuadra, A. Zurita, G. Gioino, and V. Molina Influence of different antidepressant drugs on the effect of chronic variable stress on restraint-induced dopamine release in frontal cortex Neuropsychopharmacology 25 2001 384 394
40. G. Cuadra, A. Zurita, C. Lacerra, and V. Molina Chronic stress sensitizes frontal cortex dopamine release in response to a subsequent novel stressor: reversal by naloxone Brain Res. Bull. 48 1999 303 308
41. E. Dale, H. Zhang, S.C. Leiser, Y. Chao, C. Yang, N. Plath, and C. Sanchez Vortioxetine (Lu AA21004) disinhibits pyramidal cell output and enhances theta rhythms and long-term plasticity in the hippocampus Eur. Neuropsychopharmacol. 23 2013 S394
42. D.J. David, B.A. Samuels, Q. Rainer, J.W. Wang, D. Marsteller, I. Mendez, M. Drew, D.A. Craig, B.P. Guiard, J.P. Guilloux, R.P. Artymyshyn, A.M. Gardier, C. Gerald, I.A. Antonijevic, E.D. Leonardo, and R. Hen Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression Neuron 62 2009 479 493
43. L. Dazzi, E. Seu, G. Cherchi, and G. Biggio Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress Eur. Neuropsychopharmacol. 15 2005 283 290
44. A. Degroot, and G.G. Nomikos Fluoxetine disrupts the integration of anxiety and aversive memories Neuropsychopharmacology 30 2005 391 400
45. P.L. Delgado, D.S. Charney, L.H. Price, G.K. Aghajanian, H. Landis, and G.R. Heninger Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan Arch. Gen. Psychiatry 47 1990 411 418
46. C.A. Denny, N.S. Burghardt, D.M. Schachter, R. Hen, and M.R. Drew 4- to 6-week-old adult-born hippocampal neurons influence novelty-evoked exploration and contextual fear conditioning Hippocampus 22 2012 1188 1201
47. O. Deschaux, G. Spennato, J.L. Moreau, and R. Garcia Chronic treatment with fluoxetine prevents the return of extinguished auditory-cued conditioned fear Psychopharmacology 215 2011 231 237
48. S. de St Hilaire-Kafi, and J.M. Gaillard Hypnotic action of flunitrazepam in the rat: does 5-HT mechanism play a role? Neuropharmacology 27 1988 1227 1230
49. G. Di Chiara, P. Loddo, and G. Tanda Reciprocal changes in prefrontal and limbic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: implications for the psychobiology of depression Biol. Psychiatry 46 1999 1624 1633
50. I. Dincheva, C.E. Glatt, and F.S. Lee Impact of the BDNF Val66Met polymorphism on cognition: implications for behavioral genetics Neuroscientist 18 2012 439 451
51. W. Dimpfel Preclinical data base of pharmaco-specific rat EEG fingerprints (tele-stereo-EEG) Eur. J. Med. Res. 8 2003 199 207
52. V.M. Dotson, C. Davatzikos, M.A. Kraut, and S.M. Resnick Depressive symptoms and brain volumes in older adults: a longitudinal magnetic resonance imaging study J. Psychiatry Neurosci. 34 2009 367 375
53. M.R. Drew, C.A. Denny, and R. Hen Arrest of adult hippocampal neurogenesis in mice impairs single- but not multiple-trial contextual fear conditioning Behav. Neurosci. 124 2010 446 454
54. H.C. Dringenberg, P. Diavolitsis, and P.A. Noseworthy Effect of tacrine on EEG slowing in the rat: enhancement by concurrent monoamine therapy Neurobiol. Aging. 21 2000 135 143
55. I. Driscoll, S.R. Howard, J.C. Stone, M.H. Monfils, B. Tomanek, W.M. Brooks, and R.J. Sutherland The aging hippocampus: a multi-level analysis in the rat Neuroscience 139 2006 1173 1185
56. K.G. du Jardin, J.B. Jensen, C. Sanchez, and A.L. Pehrson Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism Eur. Neuropsychopharmacol. 24 2014 160 171
57. K.G. du Jardin, N. Liebenberg, H. Müller, C. Sanchez, G. Wegener, and B. Elfving Single dose vortioxetine or ketamine but not fluoxetine increases expression of neuroplasticity related genes in the rat prefrontal cortex Eur. Neuropsychopharmacol. 23 2013 S392
58. Y. Elgersma, J.D. Sweatt, and K.P. Giese Mouse genetic approaches to investigating calcium/calmodulin-dependent protein kinase II function in plasticity and cognition J. Neurosci. 24 2004 8410 8415
59. N. Elizalde, F.J. Gil-Bea, M.J. Ramirez, B. Aisa, B. Lasheras, J. Del Rio, and R.M. Tordera Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment Psychopharmacology 199 2008 1 14
60. W. El Hage, S. Peronny, G. Griebel, and C. Belzung Impaired memory following predatory stress in mice is improved by fluoxetine Prog. Neuropsychopharmacol Biol. Psychiatry 28 2004 123 128
61. T.M. Eriksson, S. Holst, T.L. Stan, T. Hager, B. Sjogren, S.O. Ogren, P. Svenningsson, and O. Stiedl 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors Neuropharmacology 63 2012 1150 1160
62. B. Feige, U. Voderholzer, D. Riemann, R. Dittmann, F. Hohagen, and M. Berger Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects Neuropsychopharmacology 26 2002 246 258
63. J.M. Finlay, and M.J. Zigmond The effects of stress on central dopaminergic neurons: possible clinical implications Neurochem. Res. 22 1997 1387 1394
64. J.F. Flood, and A. Cherkin Fluoxetine enhances memory processing in mice Psychopharmacology 93 1987 36 43
65. K. Fujino, T. Yoshitake, O. Inoue, N. Ibii, J. Kehr, J. Ishida, H. Nohta, and M. Yamaguchi Increased serotonin release in mice frontal cortex and hippocampus induced by acute physiological stressors Neurosci. Lett. 320 2002 91 95
66. P.J. Gresch, A.F. Sved, M.J. Zigmond, and J.M. Finlay Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat J. Neurochem. 63 1994 575 583
67. B.S. Gronier, and K. Rasmussen Electrophysiological effects of acute and chronic olanzapine and fluoxetine in the rat prefrontal cortex Neurosci. Lett. 349 2003 196 200
68. N. Grunbaum-Novak, M. Taler, I. Gil-Ad, A. Weizman, H. Cohen, and R. Weizman Relationship between antidepressants and IGF-1 system in the brain: possible role in cognition Eur. Neuropsychopharmacol. 18 2008 431 438
69. J.P. Guilloux, I. Mendez-David, A. Pehrson, B.P. Guiard, C. Reperant, S. Orvoen, A.M. Gardier, R. Hen, B. Ebert, S. Miller, C. Sanchez, and D.J. David Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice Neuropharmacology 73 2013 147 159
70. E. Gumuslu, O. Mutlu, D. Sunnetci, G. Ulak, I.K. Celikyurt, N. Cine, and F. Akar The effects of tianeptine, olanzapine and fluoxetine on the cognitive behaviors of unpredictable chronic mild stress-exposed mice Drug. Res. 63 2013 532 539
71. N. Haddjeri, A. Etievant, A. Pehrson, C. Sanchez, and C. Betry Effects of the multimodal antidepressant Lu AA21004 on rat synaptic and cellular hippocampal plasticity and memory recognition Eur. Neuropsychopharmacol. 22 2012 S303
72. T. Harmony The functional significance of delta oscillations in cognitive processing Front. Integr. Neurosci. 7 2013 83
73. B.H. Harvey, C. Naciti, L. Brand, and D.J. Stein Serotonin and stress: protective or malevolent actions in the biobehavioral response to repeated trauma? Ann. N. Y. Acad. Sci. 1032 2004 267 272
74. K. Hashimoto, Y. Fujita, and M. Iyo Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors Neuropsychopharmacology 32 2007 514 521
75. K.A. Holick, D.C. Lee, R. Hen, and S.C. Dulawa Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor Neuropsychopharmacology 33 2008 406 417
76. C.S. Humpston, C.M. Wood, and E.S. Robinson Investigating the roles of different monoamine transmitters and impulse control using the 5-choice serial reaction time task J. Psychopharmacol. 27 2013 213 221
77. D. Ibi, K. Takuma, H. Koike, H. Mizoguchi, K. Tsuritani, Y. Kuwahara, H. Kamei, T. Nagai, Y. Yoneda, T. Nabeshima, and K. Yamada Social isolation rearing-induced impairment of the hippocampal neurogenesis is associated with deficits in spatial memory and emotion-related behaviors in juvenile mice J. Neurochem. 105 2008 921 932
78. M. Ivarsson, L.M. Paterson, and P.H. Hutson Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats Eur. J. Pharmacol. 522 2005 63 67
79. L.A. Jans, G.A. Korte-Bouws, S.M. Korte, and A. Blokland The effects of acute tryptophan depletion on affective behaviour and cognition in Brown Norway and Sprague Dawley rats J. Psychopharmacol. 24 2010 605 614
80. J.H. Jansen, and J.S. Andrews The effects of serotonergic drugs on short-term spatial memory in rats J. Psychopharmacol. 8 1994 157 163
81. T.A. Jenkins, M.K. Harte, and G.P. Reynolds Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the rat Neurosci. Lett. 471 2010 144 147
82. J.B. Jensen, K.G. du Jardin, D. Song, D. Budac, G. Smagin, C. Sanchez, and A.L. Pehrson Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation Eur. Neuropsychopharmacol. 24 2014 148 159
83. J.D. Jett, and D.A. Morilak Too much of a good thing: blocking noradrenergic facilitation in medial prefrontal cortex prevents the detrimental effects of chronic stress on cognition Neuropsychopharmacology 38 2013 585 595
84. N.N. Karpova, A. Pickenhagen, J. Lindholm, E. Tiraboschi, N. Kulesskaya, A. Agustsdottir, H. Antila, D. Popova, Y. Akamine, A. Bahi, R. Sullivan, R. Hen, L.J. Drew, and E. Castren Fear erasure in mice requires synergy between antidepressant drugs and extinction training Science 334 2011 1731 1734
85. A. Katoh, M. Eigyo, C. Ishibashi, Y. Naitoh, M. Takeuchi, N. Ibii, M. Ikeda, and A. Matsushita Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats J. Pharmacol. Exp. Ther. 272 1995 1067 1075
86. C. Katona, T. Hansen, and C.K. Olsen A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder Int. Clin. Psychopharmacol. 27 2012 215 223
87. X. Khawaja, J. Xu, J.J. Liang, and J.E. Barrett Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: implications for depressive disorders and future therapies J. Neurosci. Res. 75 2004 451 460
88. J.J. Kim, and D.M. Diamond The stressed hippocampus, synaptic plasticity and lost memories Nat. Rev. Neurosci. 3 2002 453 462
89. V. Knott, C. Mahoney, S. Kennedy, and K. Evans EEG correlates of acute and chronic paroxetine treatment in depression J. Affect Disord. 69 2002 241 249
90. G. Komlosi, G. Molnar, M. Rozsa, S. Olah, P. Barzo, and G. Tamas Fluoxetine (prozac) and serotonin act on excitatory synaptic transmission to suppress single layer 2/3 pyramidal neuron-triggered cell assemblies in the human prefrontal cortex J. Neurosci. 32 2012 16369 16378
91. M. Lader, A. Melhuish, G. Frcka, K. Fredricson Overo, and V. Christensen The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects Eur. J. Clin. Pharmacol. 31 1986 183 190
92. M.D. Lapiz-Bluhm, and D.A. Morilak A cognitive deficit induced in rats by chronic intermittent cold stress is reversed by chronic antidepressant treatment Int. J. Neuropsychopharmacol. 13 2010 997 1009
93. M.D. Lapiz-Bluhm, A.E. Soto-Pina, J.G. Hensler, and D.A. Morilak Chronic intermittent cold stress and serotonin depletion induce deficits of reversal learning in an attentional set-shifting test in rats Psychopharmacology 202 2009 329 341
94. M.D. Lapiz, C.O. Bondi, and D.A. Morilak Chronic treatment with desipramine improves cognitive performance of rats in an attentional set-shifting test Neuropsychopharmacology 32 2007 1000 1010
95. K. Lebron-Milad, A. Tsareva, N. Ahmed, and M.R. Milad Sex differences and estrous cycle in female rats interact with the effects of fluoxetine treatment on fear extinction Behav. Brain Res. 253 2013 217 222
96. T.A. LeGates, C.M. Altimus, H. Wang, H.K. Lee, S. Yang, H. Zhao, A. Kirkwood, E.T. Weber, and S. Hattar Aberrant light directly impairs mood and learning through melanopsin-expressing neurons Nature 491 2012 594 598
97. S.C. Leiser, J. Dunlop, M.R. Bowlby, and D.M. Devilbiss Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research Biochem. Pharmacol. 81 2011 1408 1421
98. S.C. Leiser, A.L. Pehrson, P.J. Robichaud, and C. Sanchez The multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine - a quantitative electroencephalographic study in the rat Br. J. Pharmacol. 2014 10.1111/bph.12782
99. Y. Li, C. Sanchez, and M. Gulinello Memory impairment in old mice is differentially sensitive to different classes of antidepressants Eur. Neuropsychopharmacol. 23 2013 S282
100. C.K. Lieben, K. van Oorsouw, N.E. Deutz, and A. Blokland Acute tryptophan depletion induced by a gelatin-based mixture impairs object memory but not affective behavior and spatial learning in the rat Behav. Brain Res. 151 2004 53 64
101. J.S. Lindahl, and J. Keifer Glutamate receptor subunits are altered in forebrain and cerebellum in rats chronically exposed to the NMDA receptor antagonist phencyclidine Neuropsychopharmacology 29 2004 2065 2073
102. A.C. Linthorst, and J.M. Reul Stress and the brain: solving the puzzle using microdialysis Pharmacol. Biochem. Behav. 90 2008 163 173
103. R. Luthringer, M. Toussaint, N. Schaltenbrand, P. Bailey, P.H. Danjou, D. Hackett, J.Y. Guichoux, and J.P. Macher A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression Psychopharmacol Bull. 32 1996 637 646
104. E. Malatynska, H.W. Steinbusch, O. Redkozubova, A. Bolkunov, A. Kubatiev, N.B. Yeritsyan, J. Vignisse, S. Bachurin, and T. Strekalova Anhedonic-like traits and lack of affective deficits in 18-month-old C57BL/6 mice: implications for modeling elderly depression Exp. Gerontol. 47 2012 552 564
105. J.E. Malberg, A.J. Eisch, E.J. Nestler, and R.S. Duman Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus J. Neurosci. 20 2000 9104 9110
106. R. Martinez-Turrillas, J. Del Rio, and D. Frechilla Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment Neuropharmacology 49 2005 1178 1188
107. R. Martinez-Turrillas, D. Frechilla, and J. Del Rio Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus Neuropharmacology 43 2002 1230 1237
108. E. Martisova, B. Aisa, G. Guerenu, and M.J. Ramirez Effects of early maternal separation on biobehavioral and neuropathological markers of Alzheimers disease in adult male rats Curr. Alzheimer Res. 10 2013 420 432
109. M. Matsumoto, K. Tachibana, H. Togashi, K. Tahara, T. Kojima, T. Yamaguchi, and M. Yoshioka Chronic treatment with milnacipran reverses the impairment of synaptic plasticity induced by conditioned fear stress Psychopharmacology 179 2005 606 612
110. S.M. McClintock, M.M. Husain, S.R. Wisniewski, A.A. Nierenberg, J.W. Stewart, M.H. Trivedi, I. Cook, D. Morris, D. Warden, and A.J. Rush Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication J. Clin. Psychopharmacol. 31 2011 180 186
111. L.M. McDermott, and K.P. Ebmeier A meta-analysis of depression severity and cognitive function J. Affect. Disord. 119 2009 1 8
112. R.S. McIntyre, D.S. Cha, J.K. Soczynska, H.O. Woldeyohannes, L.A. Gallaugher, P. Kudlow, M. Alsuwaidan, and A. Baskaran Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions Depress. Anxiety 30 2013 515 527
113. R.S. McIntyre, S. Lophaven, and C.K. Olsen Randomized, double-blind, placebo-controlled study of the efficacy of vortioxetine on cognitive dysfunction in adult patients with major depressive disorder (MDD) Neuropsychopharmacology 38 2013 380 381
114. T.G. Melo, G.S. Izidio, L.S. Ferreira, D.S. Sousa, P.T. Macedo, A. Cabral, A.M. Ribeiro, and R.H. Silva Antidepressants differentially modify the extinction of an aversive memory task in female rats Prog. Neuropsychopharmacol. Biol. Psychiatry 37 2012 33 40
115. J.H. Meyer, A.A. Wilson, S. Sagrati, D. Hussey, A. Carella, W.Z. Potter, N. Ginovart, E.P. Spencer, A. Cheok, and S. Houle Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study Am. J. Psychiatry 161 2004 826 835
116. M.J. Millan, Y. Agid, M. Brune, E.T. Bullmore, C.S. Carter, N.S. Clayton, R. Connor, S. Davis, B. Deakin, R.J. DeRubeis, B. Dubois, M.A. Geyer, G.M. Goodwin, P. Gorwood, T.M. Jay, M. Joels, I.M. Mansuy, A. Meyer-Lindenberg, D. Murphy, E. Rolls, B. Saletu, M. Spedding, J. Sweeney, M. Whittington, and L.J. Young Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy Nat. Rev. Drug Discov. 11 2012 141 168
117. O. Mnie-Filali, M. El Mansari, A. Espana, C. Sanchez, and N. Haddjeri Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticity Neurosci. Lett. 395 2006 23 27
118. L.P. Montezinho, S. Miller, N. Plath, N.H. Jensen, J.J. Karlsson, L. Witten, and A. Mork The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine Psychopharmacology 212 2010 131 143
119. A. Mork, A. Pehrson, L.T. Brennum, S.M. Nielsen, H. Zhong, A.B. Lassen, S. Miller, L. Westrich, N.J. Boyle, C. Sanchez, C.W. Fischer, N. Liebenberg, G. Wegener, C. Bundgaard, S. Hogg, B. Bang-Andersen, and T.B. Stensbol Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder J. Pharmacol. Exp. Ther. 340 2012 666 675
120. A. Mork, L.P. Montezinho, S. Miller, C. Trippodi-Murphy, N. Plath, Y. Li, M. Gulinello, and C. Sanchez Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats Pharmacol. Biochem. Behav. 105 2013 41 50
121. R. Mostany, E.M. Valdizan, and A. Pazos A role for nuclear beta-catenin in SNRI antidepressant-induced hippocampal cell proliferation Neuropharmacology 55 2008 18 26
122. K.J. Naegeli, J.A. O'Connor, P. Banerjee, and D.A. Morilak Effects of milnacipran on cognitive flexibility following chronic stress in rats Eur J. Pharmacol. 703 2013 62 66
123. D. Neckelmann, B. Bjorvatn, A.A. Bjorkum, and R. Ursin Citalopram: differential sleep/wake and EEG power spectrum effects after single dose and chronic administration Behav. Brain. Res. 79 1996 183 192
124. M. Nibuya, E.J. Nestler, and R.S. Duman Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus J. Neurosci. 16 1996 2365 2372
125. A.N. Nicholson, and P.A. Pascoe 5-Hydroxytryptamine and noradrenaline uptake inhibition: studies on sleep in man Neuropharmacology 25 1986 1079 1108
126. A. Nikiforuk Selective blockade of 5-HT7 receptors facilitates attentional set-shifting in stressed and control rats Behav. Brain Res. 226 2012 118 123
127. A. Nikiforuk Quetiapine ameliorates stress-induced cognitive inflexibility in rats Neuropharmacology 64 2013 357 364
128. A. Nikiforuk, and P. Popik Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants Psychoneuroendocrinology 36 2011 28 39
129. H. Okamoto, B. Voleti, M. Banasr, M. Sarhan, V. Duric, M.J. Girgenti, R.J. Dileone, S.S. Newton, and R.S. Duman Wnt2 expression and signaling is increased by different classes of antidepressant treatments Biol. Psychiatry 68 2010 521 527
130. A. Pehrson, Y. Li, N. Haddjeri, M. Gulinello, and C. Sanchez Vortioxetine, a novel multimodal antidepressant, modulates GABA and glutamate neurotransmission via serotonergic mechanisms Eur. Neuropsychopharmacol. 23 2013 S196 S197
131. A.L. Pehrson, T. Cremers, C. Betry, M.G. van der Hart, L. Jorgensen, M. Madsen, N. Haddjeri, B. Ebert, and C. Sanchez Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters - a rat microdialysis and electrophysiology study Eur. Neuropsychopharmacol. 23 2013 133 145
132. A.L. Pehrson, and C. Sanchez Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction CNS Spectr. 19 2014 121 133
133. C. Pittenger, and R.S. Duman Stress, depression, and neuroplasticity: a convergence of mechanisms Neuropsychopharmacology 33 2008 88 109
134. M. Popoli, M. Gennarelli, and G. Racagni Modulation of synaptic plasticity by stress and antidepressants Bipolar Disord. 4 2002 166 182
135. M. Popoli, A. Venegoni, C. Vocaturo, L. Buffa, J. Perez, E. Smeraldi, and G. Racagni Long-term blockade of serotonin reuptake affects synaptotagmin phosphorylation in the hippocampus Mol. Pharmacol. 51 1997 19 26
136. J.A. Pratt, C. Winchester, A. Egerton, S.M. Cochran, and B.J. Morris Modelling prefrontal cortex deficits in schizophrenia: implications for treatment Br. J. Pharmacol. 153 Suppl 1 2008 S465 S470
137. M.V. Puig, A. Watakabe, M. Ushimaru, T. Yamamori, and Y. Kawaguchi Serotonin modulates fast-spiking interneuron and synchronous activity in the rat prefrontal cortex through 5-HT1A and 5-HT2A receptors J. Neurosci. 30 2010 2211 2222
138. S. Reppermund, H. Brodaty, J.D. Crawford, N.A. Kochan, M.J. Slavin, J.N. Trollor, B. Draper, and P.S. Sachdev The relationship of current depressive symptoms and past depression with cognitive impairment and instrumental activities of daily living in an elderly population: the Sydney memory and ageing study J. Psychiatr. Res. 45 2011 1600 1607
139. G. Richter-Levin, and M. Segal Spatial performance is severely impaired in rats with combined reduction of serotonergic and cholinergic transmission Brain Res. 477 1989 404 407
140. M.S. Riga, P. Celada, C. Sanchez, and F. Artigas Role of 5-HT3 receptors in the mechanism of action of the investigational antidepressant vortioxetine Eur. Neuropsychopharmacol. 23 2013 S393 S394
141. T.W. Robbins, and A.F. Arnsten The neuropsychopharmacology of fronto-executive function: monoaminergic modulation Annu. Rev. Neurosci. 32 2009 267 287
142. B. Ryan, L. Musazzi, A. Mallei, D. Tardito, S.H. Gruber, A. El Khoury, R. Anwyl, G. Racagni, A.A. Mathe, M.J. Rowan, and M. Popoli Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression Int. J. Neuropsychopharmacol. 12 2009 553 559
143. B. Saletu, P. Anderer, and G.M. Saletu-Zyhlarz EEG topography and tomography (LORETA) in diagnosis and pharmacotherapy of depression Clin. EEG Neurosci. 41 2010 203 210
144. B. Saletu, and J. Grunberger Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses J. Clin. Psychiatry 46 1985 45 52
145. B. Saletu, and J. Grunberger Drug profiling by computed electroencephalography and brain maps, with special consideration of sertraline and its psychometric effects J Clin Psychi 49 Suppl 1988 s59 s71
146. B. Saletu, J. Grunberger, P. Anderer, L. Linzmayer, H.V. Semlitsch, and G. Magni Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology Br. J. Clin. Pharmacol. 33 1992 589 601
147. B. Saletu, J. Grunberger, P. Anderer, L. Linzmayer, and G. Zyhlarz Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and -inhibiting fluvoxamine utilizing EEG mapping and psychometry J. Neural. Transm. 103 1996 191 216
148. B. Saletu, J. Grunberger, and L. Linzmayer On central effects of serotonin re-uptake inhibitors: quantitative EEG and psychometric studies with sertraline and zimelidine J. Neural. Transm. 67 1986 241 266
149. R.J. Salin-Pascual, and M.L. Moro-Lopez Effects of venlafaxine in the sleep architecture of rats Psychopharmacology 129 1997 295 296
150. C. Sanchez, L.T. Brennum, S. Storustovu, M. Kreilgard, and A. Mork Depression and poor sleep: the effect of monoaminergic antidepressants in a pre-clinical model in rats Pharmacol. Biochem. Behav. 86 2007 468 476
151. C. Sanchez, E.H. Reines, and S.A. Montgomery A comparative review of escitalopram, paroxetine, and sertraline: are they all alike? Int. Clin. Psychopharmacol. 29 2014 185 196
152. L. Santarelli, M. Saxe, C. Gross, A. Surget, F. Battaglia, S. Dulawa, N. Weisstaub, J. Lee, R. Duman, O. Arancio, C. Belzung, and R. Hen Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants Science 301 2003 805 809
153. M.D. Saxe, F. Battaglia, J.W. Wang, G. Malleret, D.J. David, J.E. Monckton, A.D. Garcia, M.V. Sofroniew, E.R. Kandel, L. Santarelli, R. Hen, and M.R. Drew Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus Proc. Natl. Acad. Sci. USA 103 2006 17501 17506
154. B. Schilstrom, A. Konradsson-Geuken, V. Ivanov, J. Gertow, K. Feltmann, M.M. Marcus, K. Jardemark, and T.H. Svensson Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-d-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat Synapse 65 2011 357 367
155. C. Sebban, X.Q. Zhang, B. Tesolin-Decros, M.J. Millan, and M. Spedding Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission Br. J. Pharmacol. 128 1999 1045 1054
156. E. Seu, and J.D. Jentsch Effect of acute and repeated treatment with desipramine or methylphenidate on serial reversal learning in rats Neuropharmacology 57 2009 665 672
157. E. Seu, A. Lang, R.J. Rivera, and J.D. Jentsch Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys Psychopharmacology 202 2009 505 519
158. A.C. Shakesby, R. Anwyl, and M.J. Rowan Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents J. Neurosci. 22 2002 3638 3644
159. T.J. Shors, D.A. Townsend, M. Zhao, Y. Kozorovitskiy, and E. Gould Neurogenesis may relate to some but not all types of hippocampal-dependent learning Hippocampus 12 2002 578 584
160. M. Siepmann, J. Grossmann, M. Muck-Weymann, and W. Kirch Effects of sertraline on autonomic and cognitive functions in healthy volunteers Psychopharmacology 168 2003 293 298
161. T. Siepmann, M. Mueck-Weymann, R. Oertel, W. Kirch, D. Pittrow, and M. Siepmann The effects of venlafaxine on cognitive functions and quantitative EEG in healthy volunteers Pharmacopsychiatry 41 2008 146 150
162. A.J. Silva, J.H. Kogan, P.W. Frankland, and S. Kida CREB and memory Annu. Rev. Neurosci. 21 1998 127 148
163. L. Song, W. Che, W. Min-Wei, Y. Murakami, and K. Matsumoto Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress Pharmacol. Biochem. Behav. 83 2006 186 193
164. R. Stancampiano, S. Cocco, F. Melis, C. Cugusi, L. Sarais, and F. Fadda The decrease of serotonin release induced by a tryptophan-free amino acid diet does not affect spatial and passive avoidance learning Brain Res. 762 1997 269 274
165. U. Staubli, and N. Otaky Serotonin controls the magnitude of LTP induced by theta bursts via an action on NMDA-receptor-mediated responses Brain Res. 643 1994 10 16
166. D.C. Steffens, D.R. McQuoid, M.E. Payne, and G.G. Potter Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed and nondepressed subjects in the neurocognitive outcomes of depression in the elderly study Am. J. Geriatr. Psychiatry 19 2011 4 12
167. P. Stenkrona, C. Halldin, and J. Lundberg 5-HTT and 5-HT1A receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects Eur. Neuropsychopharmacol. 23 2013 1190 1198
168. M. Steriade Cellular substrates of brain rhythms E.L.D.S.F. Niedermeyer, Electroencephalography: Basic Principles, Clinical Applications and Related Fields 5th edition 2005 31 83
169. C.A. Stewart, and I.C. Reid Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity Psychopharmacology 148 2000 217 223
170. Y.P. Tang, E. Shimizu, G.R. Dube, C. Rampon, G.A. Kerchner, M. Zhuo, G. Liu, and J.Z. Tsien Genetic enhancement of learning and memory in mice Nature 401 1999 63 69
171. M. Tarn, J.G. Edwards, and E.M. Sedgwick Fluoxetine, amitriptyline and the electroencephalogram J. Affect Disord. 29 1993 7 10
172. J. Thome, N. Sakai, K. Shin, C. Steffen, Y.J. Zhang, S. Impey, D. Storm, and R.S. Duman cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment J. Neurosci. 20 2000 4030 4036
173. E. Tiraboschi, D. Tardito, J. Kasahara, S. Moraschi, P. Pruneri, M. Gennarelli, G. Racagni, and M. Popoli Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades Neuropsychopharmacology 29 2004 1831 1840
174. B. Topic, J.P. Huston, K. Namestkova, S.W. Zhu, A.H. Mohammed, and D. Schulz Extinction-induced "despair" in aged and adult rats: links to neurotrophins in frontal cortex and hippocampus Neurobiol. Learn. Mem. 90 2008 519 526
175. M.M. Torregrossa, M. Xie, and J.R. Taylor Chronic corticosterone exposure during adolescence reduces impulsive action but increases impulsive choice and sensitivity to yohimbine in male Sprague-Dawley rats Neuropsychopharmacology 37 2012 1656 1670
176. J.Y. Vargas, M. Fuenzalida, and N.C. Inestrosa In vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an alzheimers disease model J. Neurosci. 34 2014 2191 2202
177. S. Vila-Luna, S. Cabrera-Isidoro, L. Vila-Luna, I. Juarez-Diaz, J.L. Bata-Garcia, F.J. Alvarez-Cervera, R.E. Zapata-Vazquez, G. Arankowsky-Sandoval, F. Heredia-Lopez, G. Flores, and J.L. Gongora-Alfaro Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons Neuroscience 202 2012 384 395
178. D.J. Vinkers, J. Gussekloo, M.L. Stek, R.G. Westendorp, and R.C. van der Mast Temporal relation between depression and cognitive impairment in old age: prospective population based study BMJ 329 2004 881
179. J.A. Valluzzi, and K. Chan Effects of fluoxetine on hippocampal-dependent and hippocampal-independent learning tasks Behav. Pharmacol. 18 2007 507 513
180. S. Vas, Z. Katai, D. Kostyalik, D. Pap, E. Molnar, P. Petschner, L. Kalmar, and G. Bagdy Differential adaptation of REM sleep latency, intermediate stage and theta power effects of escitalopram after chronic treatment J. Neural. Transm. 120 2013 169 176
181. J. von Engelhardt, B. Doganci, V. Jensen, O. Hvalby, C. Gongrich, A. Taylor, C. Barkus, D.J. Sanderson, J.N. Rawlins, P.H. Seeburg, D.M. Bannerman, and H. Monyer Contribution of hippocampal and extra-hippocampal NR2B-containing NMDA receptors to performance on spatial learning tasks Neuron 60 2008 846 860
182. A. Wallace, A.L. Pehrson, C. Sanchez, and D.A. Morilak Vortioxetine restores reversal learning impaired by 5-HT depletion or chronic intermittent cold stress in rats Int. J. Neuropsychopharmacol. 2014 10.1017/S1461145714000571
183. L.M. Ward Synchronous neural oscillations and cognitive processes Trends Cogn. Sci. 7 2003 553 559
184. L. Westrich, A. Pehrson, H. Zhong, S.M. Nielsen, K. Frederiksen, T.B. Stensbøl, N. Boyle, M. Hentzer, and C. Sanchez In vitro and in vivo effects of the multimodal antidepressant vortioxetine (Lu AA21004) at human and rat targets Int. J. Psychiatry Clin. Pract. 5 2012 47
185. S.J. Wilson, J.E. Bailey, C. Alford, and D.J. Nutt Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteers J. Psychopharmacol 14 2000 378 386
186. S.J. Wilson, J.E. Bailey, A.S. Rich, M. Adrover, J. Potokar, and D.J. Nutt Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram Eur. Neuropsychopharmacol. 14 2004 367 372
187. Z. Yan Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications Mol. Neurobiol. 26 2002 203 216
188. J.L. Yau, J. Noble, C. Hibberd, W.B. Rowe, M.J. Meaney, R.G. Morris, and J.R. Seckl Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats J. Neurosci. 22 2002 1436 1442
189. P. Zhong, and Z. Yan Chronic antidepressant treatment alters serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons Neuroscience 129 2004 65 73
190. P. Zhong, and Z. Yan Differential regulation of the excitability of prefrontal cortical fast-spiking interneurons and pyramidal neurons by serotonin and fluoxetine PloS One 6 2011 e16970
191. F.M. Zhou, and J.J. Hablitz Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex J. Neurophysiol. 82 1999 2989 2999